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    During the period from October of 1981 through March of 1982， our research grbup in
Sapporo．treated 178 patients （158’・ males and 20 feniales） for gonorrheal infections． We
performed epidemiological and therapeutic studies on these p’atients．
    The youngesy． of the 158 male patients with acute gonorrheal urethritis was 15 years old．
The age distribution was 32 patients （20．3％） under 20 years， 46 patients （29． 1％） aged 20 to
24， 34 patients （21．5％） aged 25 to 29， 22 patie．nts （13．9％） aged 30 to 34， IO patients （6．3％）
aged 35 to 39， and 14 patients （8．9％） aged 40 to・ 54． The fact that 20％ of gonorrheal
urethritis occurred in youths under 20 years of age， is especially noteworthy．
    The infeetion in the teenage boys w．as fovnd to be picked up mostly from girls met at
discos， etc．， On the other hand， the patients in their 20s， were infected more frequently by
contact with hostesses at massage parlors and bars， these sources making up the majority of
male patients who were 25 years or older． These findings are quite interesting because they
reflect the socio－ecopomic status of the patients． ln additione the fact that hostesses working
at massage parlors are a frequent source of g，onorrheal・ urethritis infections can represent a
considerable problem in terms of public hygiene．
    The 2Q female patients with gonorrheal infections were all found ．to be cases of cervicitis，
except for a 1－year－old giri with gonorrheal infect量on of external genitals． The fact that
about half of these female patients were teenagers， aged 16 to 19 years is worth special
note．
    The duration of the latent period was less than 5 days in 83 male patients （58． 9％） with
urethritis，6～10 days i皿39 patients （27・7％）， 11～20 days in 13 patients （9．2％．），21～30 days
in 4 patients （2．8％）， and over 30 days in 2 patients （1．4％）， lt can thus be said that the
number of cases showing a long incubation period is increasing．
   The MICs of 154 gonococci strains isolated from the urethral or vaginal discharge were
determined． Thirteen （8．4％） of these clinically isola．ted strains were found to be P－lactamase
producers． When a bacterial inoculation level of 106 cells／ml was used in the in vitre MIC
determination， the MIC was 1．56 pg／ml or higher for 12 of these ．B－lactamase－producing
strains； the MIC of the 13th strain was O． 78 ptg／ml．
   At the same time， the MICs of thes6 P－lactamase－producing strains to doxycycline werc
also high； 1．56 ptg／ml or higher． These results indicate that there is a close relationship
between the mechanisms by which resistance to a血oxicillin and doxycycline is acquired．
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   The following clinical results were obtained when therapy was carried out with 1 g of
long－lasting AMPC （L－AMPC） per day （2 doses of 500 mg each） for 3 days．
   a）． Conorrheal infections caused by non P－lactamase producing strains （67 cases） ： excel－
lent efficacy ［normalized cases） in 67．2％， good （bacterial culture （一）， serous exudate （十））
in 26．9％， fair Cbacterial culture （一）， purulent exudate （十）） in 1．5％） and poor ’（bacterial
culture （＋）） in 4． 5％．
   In addition， in 15 （35．7％） of the 42 patients who’had normalized bacterial culture，
white blood cells were still detected in the urine．
   b） Gonorrheal infe． ctions caused by P－lactamase producing strains （4 cases）： excellent in
25％ （1 case）， and poor in 75％ （3cases）．
   The following clinical results were obtained when therapy was carried out for 3 days
with L－AMPC， administering 3 g （2 doses of 1，500 mg each） on the first day and 1 g on each
of the last 2 days．
   a） lnfections caused by non P－lactamase producing strains （19 cases） ： excellent ・in 73．7
％ （14 cases）， goocl in 21． i％ （4 cases）， and poor in 5．3％ （1 case） Moreover， white blood
cells were still found in the urine of 3 （25． 0％） of the 12 patients in whom the drug therapy
was evaluated as showing excellent efficacy．
   b） lnfections caused by P－lactamase producing strains （5 cases） ： excellent in 40％ （2
cases）， good in 20％ （1 case）， and poor in 40％ （2 cases）．
   The above data revealed that the administration of 3 g of’the antibiotic on only the
first day resulted in a slightly higher efficacy rate than 1 g administration on all 3 days of
therapy， but this difference was not statistically significant．
   For so皿e of the patients whose bacterial cultures still yielded gonococci at the comple－
tion of 3 days of L－AMPC therapy， regimen of 1 g／day of L－AMPC was continued for another
4 days． The clinical results as evaluated at the end of the total of 7 days of this antibiotic
therapy ・were as follows．
   a） The results in the patients suffering from gonorrheal infections from which non－P－
Iactamase producing strains were isolated were insufficient． But it is surmised that the
gonococci may have at least disappeared．
   b） The P－lactamase－producing strains had not disappeared even at the end of 7 days of
L－AMPC administration．
   On the basis of the results described above， it is concluded that the following approach
should be taken when using L－AMPC for therapy of gonorrheal infections． At first， three
days of L－AMPC dosing （1 g／day） should be performed， a dose of 3 g being administered
Qn the first day is not significantly more effective． ln about half of the patients in whom
the catisative gonococci were not eliminated by this regimen， the isolates are considered to
be P－lactamase producers．
   From the recent tendency．of increasing呈nc量dence ofβ一lactamase－producing strains， in
the future most of the such cases are presumed to be due to P－lactamase producers． With thi．s
ln mind， it is recommended that， when the culture for the gonocbcci is still positive at
the end on the 3 days of L－AMPC therapy， the antibiotic being administered should be
changed．’ When an effect is seen with 3 days of treatment， the treatment should be continued
for at least another 4 days．
   When the 1 g／day regimen of L－AMPC was continued for a total of 7 days for those
patients in whom the bacterial culture had become negative at the end of．3 days of dosing，
a serous urethral discharge was still detected in about 10％ of the patients． White blood cells
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Were still detected in the urine of about 15％ of the patients with normalized bacterial
culture．
  Side effects were not found to develop in any of the treated patients． ln addition， there
were no cases of abnormal laboratory test values that could be attributed to the administration
of the L－AMPC used in thc present study．
Key word『：Gonococcal infection，β一lactamase， L－AMPC， DOXY， CZX







































．ンターにて， （1）β一lactamase Detectioll papers
（Oxord）を用いたpaper method3）および， （2）






    日間投与
    第2日目～7日目19（力価）2分服（朝夕
    食後）6日間投与
  男子 A群 玉05症例（うち5例は治療効果の検
        討より除外）
     B群 33症例
  女子 A群 12症例
     B群 3症例
































Fig． 1． Relationship between age and infectious source in 158 cases of male gonorrheal urethritis
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  H群・AMPG感受性一DOXY耐 性
  皿群：AMPC耐 三一DOXY感受性
  W群：AMPG耐 性一DOXY耐 性
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Fig． 4． Relationship between age and infectious source
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Fig．’V． Sensitivity （MIC） distribution
and DOXY （154 strains）
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Fig． 8．Sensitivity （MIC） distribution of N． gonorrhoeae to
and DOXY （154 strains）
AMPC， CZX
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Fig． 9． Correlation between MICs of AMPC and DOXY （lnoculum
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Fig． 10． Correlation between MICs of AMPC and DOXY （lnoculum
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Fig． ll．Sensitivity （MIC） distribution of ．other organisms yielded with
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Fig．．12．Sensitivity （MIC） distribution of other organisms yielded with




Bacterial efficacy of L－AMPC just after oral administration
       VAMPC LAMPC




















＋  Gonococcus still detected丘om urethral secretion
一 ： Gonococcus didn’t detect urethral secretion
Table 2．Therapeutic efficacy of L－AMPC on male gonorrheal urethritis





Date of clinical examination
















































109 cases 92 cases
＊ 5 cases4 cases ： drug changed by another antibiotics

























Table 3． Therapeutic efficacy of L－AMPC on male gonorrheal urethritis （group A： 100 cases）




evaluation Day 3 Day 7 Total









































































67 4 10 60 3 8
81 cases 71 cases









Table 4． Therapeutic efficacy of L－AMPC on male gonorrheal urethritis （group B： 33 cases）




evaluation Day 3． Day 7 Total












































19 5 4 14 3 5
28 cases 22 cases




              ノβ一Lactamase non－producing strains
Un㎞own aboutβ・lactamase production
                        熊本・ほか：淋菌性感染症．・L－AMPC
（A crroup （L－Abfl？C 1 g／day））
    a，． Cases yielding nonβ ・一1ac七amase producing isola七e＄
                                                             67 cases
   b． Cases y．ielding te－lactamase pToaucing isolates
                                                  2卜し0％
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        Cases yielding ・non ／e－lactamase producing isolatesa．
b’；
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Fig． 14． Efficacy of L－AMPG on urethral discharge and urinary findings in male gonorrhoeal urethritis
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Table 5． Therapeutic efficacy of L－AMPC on compound




Date of clinical evaluation










Tota1 19 （100．090） 19 （100．0％）
1・ 3 dayS 七rea七men七
a． cases yielding nonβ一la’c七amase producing isola七es
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Therapeutic results of L－AMPC in fema｝e gonorrheal cervicitis
－Comparison of 3一 and 7－day treatments一
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Table 6． Therapeutic efficacy of L－AMPC on female gonorrheal cervicitis・（No． of cases treated： 15 cases）




  evaluation Day 3 Day 7 Total



































6 3 3 2 3 4
12 cases 9 cases
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Fig． 16． Comparison betWeen L－AMPC and AMPC of the time the ・effectiv．e serUm concentration












1560 泌尿紀要 29巻 ll号 1983年






























Before （ n＝t3） After





Before （n＝24） AfterBefore （n＝2A） After
2








   Fig． 17．
’Li一一N’一一’一
After Before （n＝24） After ’


































































































































































































































































         64．2％ （70例）
  有効（菌消失，漿液性分泌物残
     存）  24．8％（27例）
やや有効（菌消失，膿性分泌物残
     存）   1・896（2例）
  無効（菌残存） 9．2％（10例）
  有効（菌消失，漿液性分泌物残





   著効      68． 6％（59例）
   有効      25．6％（22例）
   やや有効     1．2％（1例）
   無効（菌残存）  4．7％（4例）
 β一lactamase産生株感染例 （9例）
   著効      33．3％（3例）
   有効      11．1％（1例）






   治療の成績
 A－a．β一lactamase非産生株感染例（67例）
       著効（正常化）   67．2％（45例）
       有効（菌消失，漿液性分泌物のみ残
          存）    26．9％（18例）
     やや有効（菌消失，膿性分泌物のみ残存）
                 1．5％ （1例）
       無効（菌残存）   4．5％（3例）
     なお，著効例中，尿中白血球を検討しえ
     た42例のうち15例（37．5％）にその残存を
     認めた，
 A－b．β一lactamase産生巣感染例（4例）
       著効25％（1例），無効75％（3例）
 B．L－AMPC初日39〔1500 mg（力価）×2〕あ
   とはA群と同じ1日lgで，3日間治療の成績
 B－a．β一lactamase非産生株感染例（19例）






       著効40％（2例），）有効20％
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